Antiproliferative and proapoptotic activities of new pyrazolo[3,4‐ d ]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells-Reference-Cited by-同舟云学术

Antiproliferative and proapoptotic activities of new pyrazolo[3,4‐ d ]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells

Published:2008-01-02 Issue:5 Volume:22 Page:1560-1571
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Spreafico Adriano¹,Schenone Silvia²,Serchi Tommaso³,Orlandini Maurizio³,Angelucci Adriano⁴,Magrini David³,Bernardini Giulia³,Collodel Giulia⁵,Di Stefano Anna³,Tintori Cristina⁶,Bologna Mauro⁴,Manetti Fabrizio⁶,Botta Maurizio⁶,Santucci Annalisa³

Affiliation:

1. Dipartimento di Medicina Clinica e Scienze Immunologiche, Policlinico Le ScotteUniversità degli Studi di Siena SienaItaly

2. Dipartimento di Scienze FarmaceuticheUniversità degli Studi di Genova GenovaItaly

3. Dipartimento di Biologia MolecolareUniversità degli Studi di Siena SienaItaly

4. Dipartimento di Biologia di Base ed ApplicataUniversit à degli Studi dell'Aquila Coppito L'AquilaItaly

5. Dipartimento di Chirurgia, Sezione di Biologia Applicata, Policlinico Le ScotteUniversità degli Studi di Siena SienaItaly

6. Dipartimento Farmaco Chimico TecnologicoUniversità degli Studi di Siena SienaItaly

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.07-9873com

Reference53 articles.

1. Osteosarcoma: Basic Science and Clinical Implications

2. Primary bone osteosarcoma in the pediatric age: State of the art

3. On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy

4. Long-Term Outcome for Patients With Nonmetastatic Osteosarcoma of the Extremity Treated at the Istituto Ortopedico Rizzoli According to the Istituto Ortopedico Rizzoli/Osteosarcoma-2 Protocol: An Updated Report

5. Biology and Therapeutic Advances for Pediatric Osteosarcoma

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-d]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma Multiforme;Pharmaceutics;2023-01-30

2. Design, synthesis, and biological evaluation with molecular dynamics study of novel pyrazolo[3,4-d]pyrimidine derivatives as anti-cancer agents;RSC Advances;2023

3. Targeting the IGF/PI3K/mTOR pathway and AXL/YAP1/TAZ pathways in primary bone cancer;Journal of Bone Oncology;2022-04

4. Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies;DNA Repair;2021-11

5. Future Directions in the Treatment of Osteosarcoma;Cells;2021-01-15